KUSHELOWITZ v. TEVA PHARMACEUTICALS, USA, INC.

CourtDistrict Court, D. New Jersey
DecidedJune 29, 2023
Docket2:22-cv-07599
StatusUnknown

This text of KUSHELOWITZ v. TEVA PHARMACEUTICALS, USA, INC. (KUSHELOWITZ v. TEVA PHARMACEUTICALS, USA, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
KUSHELOWITZ v. TEVA PHARMACEUTICALS, USA, INC., (D.N.J. 2023).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

BARRY KUSHELOWITZ, KERRI BALDWIN,

Plaintiffs, Civil Action No. 22-7599 (SDW) (JRA)

v. OPINION

TEVA PHARMACEUTICALS, USA, INC. and June 29, 2023 TEVA SALES AND MARKETING, INC.,1

Defendants.

WIGENTON, District Judge.

Before this Court is Defendants Teva Pharmaceuticals, USA, Inc. and Teva Sales and Marketing, Inc.’s (“Defendants”) Motion (D.E. 8) to Partially Dismiss Plaintiffs Barry Kushelowitz and Kerri Baldwin’s Complaint (D.E. 1 (“Compl.”)), pursuant to Federal Rules of Civil Procedure (“Rules”) 12(b)(1) and 12(b)(6). Venue is proper pursuant to 28 U.S.C. § 1391. This opinion is issued without oral argument pursuant to Rule 78. For the reasons stated herein, Defendants’ motion is DENIED. I. BACKGROUND AND PROCEDURAL HISTORY2 Defendant Teva Pharmaceuticals, USA, Inc. (“Teva”) is a global pharmaceutical company incorporated in Delaware, with its principal place of business in Parsippany, New Jersey. (Compl. ¶¶ 23, 30.) Defendant Teva Sales and Marketing, Inc. is a wholly owned subsidiary of Teva. (D.E.

1 The Clerk of Court shall amend the docket to reflect the parties’ agreement to add Teva Sales and Marketing, Inc., as a defendant in this action nunc pro tunc as of the date of the filing of the Complaint. (See D.E. 25.) 2 For purposes of the present Motion, the facts are drawn from the Complaint and accepted as true. See Fowler v. UPMC Shadyside, 578 F.3d 203, 210–11 (3d Cir. 2009). 25 at 2.)3 Plaintiffs are two individuals who worked for Teva in the role of “Sales Specialist.” (Id. ¶ 4.) When newly hired into this role, they were required to complete a rigorous training program comprised of coursework and examinations, and they regularly worked more than 40 hours per week to complete the necessary coursework and exam preparation. (Id. ¶¶ 15, 19, 32–35.)

However, Plaintiffs and other Sales Specialist trainees were not paid overtime wages during this training period because Teva had a company-wide policy of classifying them as exempt from overtime pay requirements. (Id. ¶¶ 6–7, 15–17, 19–21, 25.) Plaintiffs bring this suit on behalf of themselves and similarly situated Sales Specialists for overtime pay under the Fair Labor Standards Act (“FLSA”) and the New York Labor Law (“NYLL”). (Id. ¶¶ 66–90.) Plaintiff Baldwin completed Teva’s Sales Specialist training program in Lawrenceville, Georgia, from approximately April 2020 through October 2021. (Id. ¶ 18.) She brings claims arising under the FLSA and seeks to represent an opt-in collective of all “current and former employees of [Teva] working as Sales Specialists throughout the United States” from August 19, 2016, through the resolution of this action (the “FLSA Collective”). (Id. ¶¶ 56, 82–90.)

Plaintiff Kushelowitz completed the training program in New York, New York from approximately March through May 2019. (Id. ¶ 14.) He brings claims exclusively arising under the NYLL, and seeks to represent an opt-out class of all “current and former employees of [Teva] working as Sales Specialists [in] New York” from August 19, 2016, through the resolution of this action (the “New York Class”). (Id. ¶¶ 14, 46, 66–81.) Plaintiffs filed this putative class and collective action on December 30, 2022, having previously executed a tolling agreement with Teva which tolled the statutes of limitations for their

3 Given the lack of agreement as to which entity was Plaintiffs’ legal employer, this Court will refer to the parent company, Teva, as the employer for present purposes. (See D.E. 1 ¶¶ 3–4; D.E. 8-1 at 6 n.1; D.E. 25.) FLSA and NYLL claims effective August 19, 2022. (Compl. ¶ 46 n. 1.) In Counts One through Three of the Complaint, Plaintiff Kushelowitz asserts claims on behalf of the New York Class for unpaid overtime wages, failure to provide wage notices, and failure to provide accurate wage statements, in violation of the NYLL and related regulations promulgated by the New York State

Department of Labor. (Id. ¶¶ 66–81.) In Count Four, Plaintiff Baldwin asserts a claim on behalf of the FLSA Collective for unpaid overtime in violation of the FLSA. (Id. ¶¶ 82–90.) On January 26, 2023, Defendants answered the Complaint, asserting among other affirmative defenses that “[t]he NYLL does not contain any provision or regulation addressing outside salespersons in training, nor has the NYLL expressly adopted 29 C.F.R. § 541.705,” and that “Plaintiffs and the purported class and/or collective are exempt from applicable overtime laws.” (D.E. 5 at 18.) Defendants subsequently filed the instant motion to dismiss Counts One through Three of the Complaint—the NYLL claims—and the parties timely completed briefing. (D.E. 8, 13, 15.) II. LEGAL STANDARDS

An adequate complaint must contain “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. P. 8(a)(2). When considering a motion to dismiss under Rule 12(b)(6), a court must “accept all factual allegations as true, construe the complaint in the light most favorable to the plaintiff, and determine whether, under any reasonable reading of the complaint, the plaintiff may be entitled to relief.” Phillips v. Cnty. of Allegheny, 515 F.3d 224, 231 (3d Cir. 2008) (quoting Pinker v. Roche Holdings Ltd., 292 F.3d 361, 374 n.7 (3d Cir. 2002)). However, “the tenet that a court must accept as true all of the allegations contained in a complaint is inapplicable to legal conclusions.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009); see also Fowler v. UPMC Shadyside, 578 F.3d 203, 210–11 (3d Cir. 2009) (discussing the Iqbal standard). This Court has original jurisdiction over civil actions arising under federal law, such as the FLSA, and it may generally exercise supplemental jurisdiction over state law claims that are “so related” to the claims within its original jurisdiction “that they form part of the same case or controversy.” 28 U.S.C. §§ 1331, 1367; see Higgins v. Bayada Home Health Care Inc., 62 F.4th

755, 758 n.8 (3d Cir. 2023). A district court may decline to exercise jurisdiction over a state law claim that “raises a novel or complex issue of State law,” that “substantially predominates over the [federal] claim,” or that presents “other compelling reasons for declining jurisdiction.” 28 U.S.C. § 1367(c). III. DISCUSSION Defendants move to dismiss the NYLL claims, asserted in Counts One through Three of the Complaint, for failure to state a claim. (D.E. 8-1 at 9–15.)4 In the alternative, Defendants argue that the NYLL claims should be dismissed for lack of subject matter jurisdiction and that this Court should decline to exercise supplemental jurisdiction over them as a matter of discretion. (Id. at 15–24.) For the following reasons, this Court will deny the instant motion to dismiss as

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Icicle Seafoods, Inc. v. Worthington
475 U.S. 709 (Supreme Court, 1986)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Knepper v. Rite Aid Corp.
675 F.3d 249 (Third Circuit, 2012)
De Asencio v. Tyson Foods, Inc.
342 F.3d 301 (Third Circuit, 2003)
Avraham Gold v. New York Life Insurance Co.
730 F.3d 137 (Second Circuit, 2013)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Gorey v. MANHEIM SERVICES CORPORATION
788 F. Supp. 2d 200 (S.D. New York, 2011)
Lyon v. Whisman
45 F.3d 758 (Third Circuit, 1995)
Gold v. New York Life Insurance Co.
2017 NY Slip Op 5695 (Appellate Division of the Supreme Court of New York, 2017)
Encino Motorcars, LLC v. Navarro
584 U.S. 79 (Supreme Court, 2018)
Hayward v. IBI Armored Servs.
954 F.3d 573 (Second Circuit, 2020)
Anderson v. Ikon Office Solutions, Inc.
38 A.D.3d 317 (Appellate Division of the Supreme Court of New York, 2007)
Mazzarella v. Fast Rig Support, LLC
823 F.3d 786 (Third Circuit, 2016)
Snyder v. Dietz & Watson, Inc.
837 F. Supp. 2d 428 (D. New Jersey, 2011)
Marcus v. AXA Advisors, LLC
307 F.R.D. 83 (E.D. New York, 2015)
Stephanie Higgins v. Bayada Home Health Care Inc
62 F.4th 755 (Third Circuit, 2023)
Gold v. New York Life Ins. Co.
32 N.Y.3d 1009 (New York Court of Appeals, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
KUSHELOWITZ v. TEVA PHARMACEUTICALS, USA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kushelowitz-v-teva-pharmaceuticals-usa-inc-njd-2023.